SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Author: Business Wire
Sapio Sciences Selected by LabConnect to Transform Laboratory Operations
BALTIMORE–(BUSINESS WIRE)–Sapio Sciences, the science-aware™ lab informatics platform, today announced that LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally tran…
McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ophthalmology and retin…
Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Intraocular Lens Market Projected to Reach US$ 7.16 Billion by 2033 with Notable CAGR of 5.40%, Expansion Fueled by Aging Population and Technological Advancements – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market Report by Product, Material, End User, Region and Company Analysis 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The global Intraocular Lens (IOL) market is poised for subst…
VetnCare Announces Matthew J. Kirchner as Chief Executive Officer; Founder Dr. Andrew Moffatt to Continue Leadership Role as Chief Medical Officer
OAKLAND, Calif.–(BUSINESS WIRE)–VetnCare (or “the Company”), a growing community of veterinary hospitals based in Northern California, has appointed Matthew J. Kirchner as Chief Executive Officer. As part of the transition, Founder Dr. Andrew Moffatt…
Marshall B. Ketchum University’s Dr. Susan Cotter Garners Global Recognition for Transformative Impact in Optometry
FULLERTON, Calif.–(BUSINESS WIRE)–Marshall B. Ketchum University (MBKU) today announced that esteemed professor and associate dean for university research, Dr. Susan Cotter, OD, MS, FAAO, has been honored with two of optometry’s most distinguished ac…
Maui Jim and Oracle Red Bull Racing Prepare for an Exciting Journey Together Through a New Multi-Year Partnership
PEORIA, Ill.–(BUSINESS WIRE)–Maui Jim and Oracle Red Bull Racing are thrilled to announce a new multi-year partnership, building on the strong foundation established through Maui Jim’s collaboration with Red Bull Global Sports, which began in 2024. T…
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora (NYSE: COR). Harrow Cares…
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related assets to PRN Physician Recommended Nutriceuticals, L…
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release fourt…
Des économies en vue : Specsavers réalise d’importantes économies sur trois ans en transférant sa fonction d’assistance d’Oracle à Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), à qui des entreprises du monde entier font confiance pour le support de leurs logiciels essentiels Oracle, SAP et VMware, a annoncé aujourd’hui qu’elle va permettre à Specsavers, spécialiste mondi…
Kostensenkung in Sicht: Specsavers profitiert von erheblichen Einsparungen durch die Umstellung von Oracle zu Spinnaker Support über drei Jahre
DENVER, Colorado, USA–(BUSINESS WIRE)–Spinnaker Support (Spinnaker) – ein Anbieter von Supportleistungen, dem Unternehmen weltweit bei der Unterstützung ihrer unverzichtbaren Oracle-, SAP- und VMware-Software vertrauen – wird dem globalen Augen- und …
Riassunto: Risparmi in vista: tre anni di grandi risparmi per Specsavers, spostando il passaggio della funzionalità di supporto da Oracle a Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), società di fiducia di aziende di tutto il mondo per supportare il software essenziale Oracle, SAP e VMware, oggi ha annunciato che consentirà lo Specsavers, lo specialista globale di ottica e cura…
Resumen: Ahorro a la vista: Specsavers consigue un importante ahorro en tres años al trasladar la función de soporte técnico de Oracle a Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), empresa en la que confían compañías de todo el mundo para el soporte técnico de su software fundamental de Oracle, SAP y VMware, anuncia hoy que permitirá a Specsavers, especialista internacional …
Samenvatting: Besparingen in zicht: de komende drie jaar verwezenlijkt Specsavers aanzienlijke besparingen door de supportfunctie van Oracle naar Spinnaker Support te verplaatsen
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), waar bedrijven van over de hele wereld beroep op doen om hun essentiële Oracle-, SAP- en VMware-software te ondersteunen, maakte vandaag bekend dat het de internationale specialist in oogzorg en g…
Pantheon Vision Announces Third Successful Meeting with the FDA Review Team
BALTIMORE–(BUSINESS WIRE)–Pantheon Vision Announces Third Successful Meeting with the FDA Review Team
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial results on Wednesday,…
Savings in Sight: Specsavers Makes Significant Savings Over Three Years by Moving Support Function from Oracle to Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), trusted by companies worldwide to support their essential Oracle, SAP and VMware software, today announces that it will enable global eyecare and hearing specialist Specsavers to achieve significa…
Ophthalmic Disease Therapeutics Market Research with Analyst Recommendations – Focus on Rare Eye Diseases / Growing Role of Artificial Intelligence in Diagnosis and Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By Therapies, By Distribution Channel, By Region, By Countr…